Loading...
The development of immunoconjugates for targeted cancer therapy
Immunoconjugates are specific, highly effective, minimally toxic anticancer therapies that are beginning to show promise in the clinic. Immunoconjugates consist of three separate components: an antibody that binds to a cancer cell antigen with high specificity, an effector molecule that has a high c...
Na minha lista:
| Udgivet i: | Nat Rev Clin Oncol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4700536/ https://ncbi.nlm.nih.gov/pubmed/25265912 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2014.159 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|